UTHR's logo.
Ticker Symbol: UTHR

United Therapeutics Corp

$203.24 - 07-11-2024 4 p.m. ET

Exchange: NASDAQ Country: United States Currency: USD Asset Type: Common Stock CIK:0001082554

Company Profile

United Therapeutics Corporation focuses on the strength of a balanced, value-creating biotechnology model. We are confident in our future thanks to our fundamental attributes, namely our obsession with quality and innovation, the power of our brands, our entrepreneurial culture and our bioinformatics leadership. We also believe that our determination to be responsible citizens - having a positive impact on patients, the environment and society - will sustain our success in the long term. Through our wholly-owned subsidiary, Lung Biotechnology PBC, we are focused on addressing the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply. Lung Biotechnology is the first public benefit corporation subsidiary of a public biotechnology or pharmaceutical company.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 1040 Spring St
CEO: Martine Rothblatt
Tags:
  • Health Technology
  • Pharmaceuticals: Other
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $221.49
Change: -$0.65 ( -0.29%)
Days Range: $217.61 - $221.84
Beta: 0.19
52wk. High: $283.08
52wk. Low: $204.44
Ytd. Change -20.41%
50 Day Moving Average: $226.33
200 Day Moving Average: $226.32
Shares Outstanding: 46932640

Valuation

Market Cap: 1.0T
PE Ratio: 12.53
EPS (TTM): 17.67

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A